Stand up for the facts!
Our only agenda is to publish the truth so you can be an informed participant in democracy.
We need your help.
I would like to contribute
Photo of a blacklegged tick — also known as a deer tick. (CDC via AP)
If Your Time is short
-
Lyme disease is the most common tick-borne infectious disease in the United States. There is no vaccine to protect against it in humans.
-
Biopharmaceutical company Pfizer and Valneva, a European vaccine company, are developing a vaccine because of the illness’ growing global prevalence and its potential for serious complications.
-
For now, the best way to avoid Lyme disease is to prevent tick bites by using insect repellent, wearing long, protective clothing outside and conducting thorough tick checks of yourself and pets after time spent outdoors.
Spring’s budding trees, blooming flowers and warmer temperatures beckon the winter weary back outdoors. But a tiny danger lurks in the season’s celebratory greenery: ticks.
These eight-legged, bacteria-carrying parasites are the No. 1 Lyme disease-spreader for humans. Scientists are working on a vaccine series to guard against the disease. Until then, people are vulnerable to this potentially serious tick-borne illness — and the risk of exposure is growing. Some antivaccine sentiment is propelling an online conspiracy theory linking the tick population with the vaccine.
So before you set out on that hike, picnic or beach day, know the facts about ticks, Lyme disease and the vaccine in development to prevent it.
What is Lyme disease?
Lyme disease is the most common tick-borne infectious disease in the United States. Named for the Connecticut town where it was first reported in the 1970s, Lyme is prevalent in the northeast and upper midwest. Its geographic distribution also includes the west coast and regions such as Canada, Europe and Asia — and it’s spreading.
Humans usually contract Lyme after they’re bitten by a deer tick carrying the borrelia bacteria that causes Lyme.
Untreated Lyme disease infections typically begin with a rash, fever, headache, fatigue, swollen lymph nodes or muscle and joint aches and stiffness. Infections progress in stages, moving to other parts of your body such as the heart, brain or spinal cord. Months after the tick bite, untreated infections can cause arthritis, brain fog, nerve damage and mental health issues.
Lyme disease can be treated with a complete round of antibiotics. Many people see improvement, but some people report long-lasting symptoms for months or years.
An informational card about ticks distributed by the Maine Medical Center Research Institute is seen in the woods in Freeport, Maine, May 9, 2014. (AP)
Why is Lyme spreading to new geographic areas?
Ticks are expanding their geographic range at the same time climate change’s warmer temperatures and higher humidity are prolonging tick season.
Suburban development broke up woodland areas and put large numbers of people right at the edge of ticks’ favored habitats, said Dr. Jake Scott, an infectious disease specialist and a Stanford University School of Medicine professor.
The result is more ticks, a longer tick season and more people living near tick habitats — and more Lyme disease cases.
In 2023, the most recent year for which data is available, state health departments reported more than 89,000 cases of Lyme disease. Lyme disease is likely even more prevalent, though. Using insurance claims data, researchers estimate that about 476,000 people annually are diagnosed with and treated for Lyme disease.
How does the latest proposed vaccine work?
Pfizer began researching a new Lyme disease vaccine because of the illness’ growing prevalence, its status as a global public health concern, and its potential for serious complications, the company said in a statement to PolitiFact.
Pfizer and Valneva, a European vaccine company, are working on a vaccine that would cause a person’s body to create protective antibodies against a protein found on the borrelia bacteria’s surface. If a tick bites a vaccinated person, it ingests blood that contains the antibodies that fight the Lyme disease by attaching themselves to the bacteria’s surface. This renders the bacteria inactive and unable to infect a human host.
The vaccine was tested in a large-scale clinical trial in which participants were randomly selected to receive either a placebo or an actual vaccine. The trial was conducted in areas of the U.S., Canada and Europe with high numbers of Lyme disease cases. It involved about 9,400 people, ages 5 and older. Participants received an initial three-dose vaccine series and then a booster shot about a year after completing the series, which was timed to fall just before peak Lyme disease season.
Compared with the placebo, early trial results show that four doses of the vaccine were about 75% effective at reducing the rate of confirmed Lyme disease cases on the day after the last dose and 73% effective in reducing the rate of confirmed Lyme disease cases 28 days later.
Pfizer said the trial saw fewer cases of Lyme disease than expected.
That means the results weren’t as statistically meaningful as the study’s goal. Still, 73% efficacy against a disease with no other vaccine is significant, Scott said.
Pfizer said the trial results established "clinically meaningful efficacy" and said the company plans to pursue regulatory approval.
If it were approved by the Food and Drug Administration, traditionally a CDC vaccine committee would establish recommendations for who should be vaccinated.
Health and Human Services Secretary Robert F. Kennedy Jr. has pledged to fight for Lyme treatment and prevention.
It’s unclear if U.S. public health agencies — led by Kennedy, a longtime antivaccine activist — would approve the vaccine.

Robert Terwilliger, right, of Williamsburg, Pa., who is participating in a Lyme disease vaccine trial at the Altoona Center for Clinical Research, is injected with either the new vaccine or a placebo, by registered nurse Janae Roland, Aug. 5, 2022. (AP)
Wasn’t there another Lyme disease vaccine years ago?
Yes. The FDA approved a Lyme disease vaccine called LYMErix in 1998. LYMErix worked similarly to Pfizer and Valneva’s vaccine and showed about 75% efficacy in clinical trials. But where LYMErix targeted only one strain of bacteria, the vaccine currently in development targets six strains of Lyme bacteria.
LYMErix’s manufacturer withdrew the vaccine in 2002, citing low demand and poor sales following health officials’ lukewarm recommendations and amid antivaccine sentiment.
What’s behind social media posts about boxes of ticks being delivered to farms?
Both vaccines and Lyme disease have long been fodder for conspiracy theories.
Pfizer’s recent vaccine clinical trial results sparked social media posts promoting unsubstantiated conspiracy theories that boxes of ticks were being mailed to farmers throughout the U.S. and that the government would soon release "plague like levels of ticks" to incentivize people to get vaccinated.
Snopes investigated Missouri-specific tick rumors, and found no health or law enforcement officials in the state who’d received any reports of boxes of ticks being left on farms.

A woman walks a dog at Robert W. Crown Memorial State Beach Park in Alameda, Calif., Jan. 1, 2026. Conduct regular tick checks on pets that spend time outside. (AP)
Without a vaccine, what’s the best way to avoid Lyme disease?
Avoid tick bites. Use insect repellent and wear long, protective clothing when spending time outdoors. It also helps if that clothing is treated with permethrin, an insecticide that kills ticks. (Note: You can apply permethrin to clothes and outdoor gear, but you cannot apply it directly to the skin and it’s toxic to cats.)
These measures can protect you from other tick-borne diseases, too.
A tick has more time it has to transmit the bacteria that causes Lyme disease the longer it remains attached, so it’s best to remove ticks quickly if you’re bitten.
Conduct thorough tick checks regularly for yourself, your children and outdoor pets such as the family dog.
PolitiFact Researcher Caryn Baird and Senior Digital Research Analyst Jeff Cercone contributed to this report.
RELATED FACT-CHECK: Was Lyme disease spread as a bioweapon? No, that theory is Pants on Fire!
Our Sources
Dr. Jake Scott, clinical associate professor in the division of infectious diseases and geographic medicine at Stanford University School of Medicine, April 20, 2026
Dr. Daniel Cameron, a physician with clinical experience treating Lyme disease and other tick-borne illnesses, April 16, 2026
Emailed statement from Pfizer, April 13, 2026
X post, April 19, 2026 (archived)
Stanford Medicine News Center, Sorting Lyme disease fact from fiction with Stanford Medicine’s Jake Scott, Sept. 2, 2025
Mayo Clinic, Lyme disease, accessed April 16, 2026
Cleveland Clinic, Lyme Disease: Causes, Rash, Symptoms & Treatment, accessed April 16, 2026
Johns Hopkins Medicine Lyme Disease Research Center, How has Lyme disease expanded since its first discovery? accessed April 16, 2026
State of Connecticut, A Brief History of Lyme Disease in Connecticut, accessed April 16, 2026
Tulane National Biomedical Research Center, Lyme Disease, accessed April 16, 2026
U.S. Centers for Disease Control and Prevention, Lyme Disease Surveillance and Data, March 13, 2025
Yale School of Medicine, Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes, Aug. 28, 2017
Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Lyme and Tickborne Diseases Dashboard, April 16, 2026
Johns Hopkins Bloomberg School of Public Health, Geography, Ticks and You | Johns Hopkins Lyme and Tickborne Diseases Dashboard, accessed April 20, 2026
U.S. Centers for Disease Control and Prevention, Lyme Disease Case Maps, June 4, 2025
U.S. Centers for Disease Control and Prevention, Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010–2018 accessed Jan. 13, 2021
Oxford Academic’s Journal of Medical Entomology, County-Scale Distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the Continental United States, March 2016
Portland Press Herald, MaineHealth helping test new Lyme vaccine, May 7, 2024
Northwestern Now, Taking the bite out of Lyme disease, April 25, 2025
NBC News, Pfizer Lyme vaccine shows more than 70% efficacy but misses key statistical goal, March 23, 2026
CIDRAP, Lyme disease vaccine shows over 70% efficacy in phase 3 trial, March 24, 2026
Pfizer, What You Need to Know About a Promising Vaccine Candidate that May Stem the Growing Risk of Lyme Disease, March 23, 2026
Valneva, Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial, March 23, 2026
CNN, RFK Jr. pledged to fight Lyme disease. Does that include supporting a vaccine?, March 31, 2026
BU Today, Tick-Borne Diseases Risk Increasing Due to Climate Change: What You Need to Know, May 14, 2025
Association of Health Care Journalists, Lyme disease on the rise as climate change expands tick range, April 4, 2026
Children's Hospital of Philadelphia, Removing Ticks: The Dos and Don’ts, April 29, 2025
U.S. Centers for Disease Control and Prevention, What to Do After a Tick Bite, July 15, 2025
Johns Hopkins Medicine Lyme Disease Research Center, 5 Tips for Preventing Tick Bites and Lyme Disease, March 19, 2019
Lyme Wellness Initiative, Preventing Tick Bites, accessed April 20, 2026
FirstWord Pharma, Third booster of Pfizer, Valneva's Lyme shot shows sustained immune response, Sept. 3, 2025
Global Lyme Alliance, Lyme Disease Crisis Addressed During HHS Hearing, March 17, 2025
American Lyme Disease Foundation, Lyme Disease, accessed April 20, 2026
Harvard Health Publishing, Lyme disease: Resolving the "Lyme wars," June 18, 2018
Maryland Department of Health and Mental Hygiene and the Lyme Disease Research Foundation of Maryland, Looking for a bull’s-eye? You could be way off target when diagnosing Lyme disease, accessed April 20, 2026
Johns Hopkins Medicine Lyme Disease Research Center, Frequently Asked Questions (FAQs), accessed April 20, 2026
Lyme Wellness Initiative, Persistent Symptoms of Lyme disease, accessed April 20, 2026
Lyme Wellness Initiative, Lyme Disease Stages and Symptoms, accessed April 20, 2026
USA Today, New Pfizer Lyme disease vaccine shows promise. Here's how it works., March 25, 2026
Scientific American, Lyme disease is spreading, but a new vaccine could curb infections, April 9, 2026
Pfizer, Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disease Vaccine Candidate VLA15, Feb. 17, 2023
National Library of Medicine, Study Details | NCT05477524 | An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15), Sept. 29, 2025
AAMC, Lyme disease is on the rise. Why is there still no vaccine? Sept. 22, 2022
Time, We Used to Have a Lyme Disease Vaccine. Are We Ready to Bring One Back? June 17, 2021
The Milbank Quarterly, The Rise and Fall of the Lyme Disease Vaccines: A Cautionary Tale for Risk Interventions in American Medicine and Public Health - ARONOWITZ - 2012, June 18, 2012
Cape Cod Times, A mix of relief and concern as Lyme vaccine discontinued, April 21, 2026
National Library of Medicine, HLA Type and Immune Response to Borrelia burgdorferi Outer Surface Protein A in People in Whom Arthritis Developed After Lyme Disease Vaccination, Sept. 24, 2009
Minnesota Department of Health, Diseases that can be Transmitted by Ticks, accessed April 21, 2026
Rutgers Cooperative Extension, Diseases Transmitted by Ticks in New Jersey, accessed April 21, 2026
BBC, Why are more people getting Lyme disease? Oct. 2, 2025
PolitiFact, United Facts of America: Looking at the profit motive driving anti-vaccine misinformation, Nov. 7, 2023
PolitiFact, 'Died Suddenly' repeats debunked COVID-19 vaccine claims, promotes conspiracy theory, Nov. 29, 2022
PolitiFact, Was Lyme disease spread as a bioweapon? No, that theory is Pants on Fire! May 16, 2024
National Cancer Institute, Definition of phase III clinical trial, accessed April 27, 2026
